Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 64.97B | 63.16B | 61.92B | 60.88B | 60.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.97B | 63.16B | 61.92B | 60.88B | 60.23B |
| Cost of Revenue | 39.39B | 38.72B | 37.97B | 37.30B | 37.06B |
| Gross Profit | 25.58B | 24.44B | 23.96B | 23.58B | 23.18B |
| SG&A Expenses | 994.00M | 976.00M | 976.00M | 976.00M | 976.00M |
| Depreciation & Amortization | 3.08B | 3.04B | 3.02B | 2.99B | 2.97B |
| Other Operating Expenses | 11.88B | 11.19B | 10.67B | 10.32B | 10.18B |
| Total Operating Expenses | 55.34B | 53.92B | 52.63B | 51.59B | 51.18B |
| Operating Income | 9.63B | 9.24B | 9.29B | 9.29B | 9.05B |
| Income Before Tax | 7.71B | 8.66B | 8.74B | 8.69B | 8.58B |
| Income Tax Expenses | 1.62B | 1.79B | 1.79B | 1.78B | 1.75B |
| Earnings from Continuing Operations | 6.09K | 6.88K | 6.95K | 6.91K | 6.83K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -849.00M | -1.16B | -1.17B | -1.18B | -1.19B |
| Net Income | 5.24B | 5.72B | 5.77B | 5.73B | 5.64B |
| EBIT | 9.63B | 9.24B | 9.29B | 9.29B | 9.05B |
| EBITDA | 12.70B | 12.28B | 12.31B | 12.28B | 12.02B |
| EPS Basic | 19.17 | 20.53 | 20.52 | 20.12 | 19.41 |
| Normalized Basic EPS | 14.52 | 12.42 | 12.38 | 12.29 | 11.66 |
| EPS Diluted | 18.98 | 20.33 | 20.33 | 19.94 | 19.23 |
| Normalized Diluted EPS | 14.38 | 12.27 | 12.24 | 12.16 | 11.54 |
| Average Basic Shares Outstanding | 1.09B | 1.11B | 1.12B | 1.14B | 1.17B |
| Average Diluted Shares Outstanding | 1.11B | 1.12B | 1.13B | 1.15B | 1.18B |
| Dividend Per Share | 2.40 | 2.36 | 2.32 | 2.28 | 2.24 |
| Payout Ratio | 12.61% | 11.49% | 11.35% | 11.36% | 11.57% |